ArticleCureus2025
Bilateral Breast Reconstruction Using Extended Latissimus Dorsi Musculocutaneous Flaps for Metachronous Bilateral Breast Cancer: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 49-year-old woman had undergone radiofrequency ablation (RFA) therapy and sentinel lymph node biopsy (SNB), followed by radiation therapy for her right breast cancer at the age of 31. The patient had further undergone nipple-sparing mastectomy (NSM), SNB, and immediate breast reconstruction using an extended latissimus dorsi musculocutaneous flap (eLDMCF) for her left breast cancer at the age of 43. Follow-up mammography further revealed widespread linear calcifications in the right breast. Core needle biopsy pathologically showed atypical cells growing in trabecular and tubular fashions with connective tissue proliferation, leading to the diagnosis of invasive ductal carcinoma. Due to the patient's strong preference for not using silicone prosthesis on right breast reconstruction, the patient underwent NSM and SNB, followed by immediate breast reconstruction using the right eLDMCF after obtaining full informed consent about the unknown bilateral eLDMCF harvesting effect on respiratory function. The patient recovered uneventfully and showed respiratory function as follows: preoperative 2.69 L to postoperative 2.46 L in vital capacity and preoperative 2.1 L to postoperative 1.83 L in forced expiratory volume in one second. The patient reported no respiratory symptoms and has been fully satisfied with the cosmetic outcomes of the reconstructed right breast. These results suggest that bilateral breast reconstruction using eLDMCFs can be a good therapeutic option for metachronous bilateral breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.